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purpose of this study is to evaluate glucose utilization in the isolated rat heart
at baseline and with insulin stimulation using acafyl-FDG, which is taken
up independently of trensport. It is hydrolyzedand phosphorylatad within
the cells similarly to FDG. Heatts from fasted, male Sprague-Dawley rats
were excised and perfused according to Langendorff with Krebs-Hensleit
bicarbonate buffer containing Acetyl-FDG and 10 mM glucose at constant
pressure of 60 mmHg. After baseline measurements, hearts were perfused
with insulin (100 nM) addad to perfusate. Radioactivity was monitored using
BGO detector interfaced with a computer. Time-activity curves were decay
correctadand normalized toradioactivifyin perfuaate.Slopaswerecalculated
fmm fitted Iinearcuwesas an index of rate of tracer accumulation (ml/g/min).
Baseline accumulation of acatyl-FDG (0.155 + 0.009) was approximately
7 times faster than that of FDG (0.024 + 0.005) in the same model. After
addition of insulin, there wee a clearance ofacetyl-FDG (–0.029 + 0.001) in
contrast to results with FDG, which showed an approximately 6-fold increase
in uptake compared to baseline (0.113 + 0.057). Approximately 10 minutes
after perfusion with insulin, however, acetyl-FDG was taken up again at a
reduced rate (0.023 + 0.006, 15% of baseline).
Thus, the faster accumulation of acefyl-FDG compared to FDG provide
further evidence that transpotl is rate-limiting for glucose utili=tion at baee-
Iine in the isolated rat heart. The initial clearance of acetyl-FDG after insulin
suggest that the increase in glucose transpml stimulated by insulin increased
cellular glucose concentration, which competes with acatyl-FDG for hexok-
inase activity, causes a net back-diffusion of the tracer. After approximately
10 minutes, glucose transport again appears to be rata-limiting; hence, the
positive myocardial accumulation of acatyl-FDG. The presentad dual tracer
technique may provide new insights into the roles of transpoti and phospho-
rylation in the regulation of exogenous glucose utilization.
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m1003110 CanLsrftVentricularDiameterebe Used toAesese Left Ventricular Remodeling?
K.S. Dujardin, M. Enriquez-Sarano, A. Rossi, J.B. Seward. Mayo Clinic,
Rocheste4 MN, USA
Left ventricular diameters (LV) are easy to measure and commonly used
as substitutes for volumetric analysis to evaluate LV remodeling caused by
LV overload or dysfunction. However, their impact on outcome is disputed,
suggesting that they may notadequately aasess LVremodeling.Todetermine
thevalidityof LVdiameters intheassessment of LVremodeling, LVdiameters
by M-mode and volumes by biplane Simpson’s rule were prospectively and
simultaneously measured in 463 patienta (289 men, age 62 + 15); 46 normal
subjects, 53 with aortic regurgitation, 2S1with mitral regurgitationand83 with
LV dysfunction. The LVejection fraction (EF) and wall stress were calculated
using the M-mode and 2D volumes. The correlation between diameters and
volumes was good both at end-systole (r = 0.91, p < 0.001) and at end-
diastole (r= 0.66, p < 0.001). However, the relation was exponential with
increasing 95% C.1(sss figures). The calculated EF and wall stress using LV
diameters and using LV volumee correlated linearly with a limited range of
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error (respectively, r = 0.95, SEE= 5%, p <0.001 and r = 0.95, SEE= 10%,
p < 0.001).
Weconcludethatfor the assessment of LV remodeling M-mode diameters
1) allow acceptable estimation of EF and wall etress and 2) correlate signifi-
cantly to the LVvolumes, but 3) are hinderad by a wide range of error for the
assessment of LVsize, especially for enlarged ventricles, suggesting that LV
volume measurement should be the preferred method of echocardiographic
assessment of LV remodeling.
-~ The Dependenceofthe EwaveonPuhnonary
Venoue Flow: Mathematical Solution with In Vivo
Verification
R.Y.Grimes, R.A. Levine, A.P. Yoganathan, S.D. Nikohc. Massachusetts
General Hospitel, Boston, MA, USA, Stanford University Medical School,
Stanford, CA, USA
The E wave has become parl of our aaaeesment of LV diastolic function.
However, it is load-dependent and varies with left atrial pressure (LAP). This
pressure is supported by pulmona~ venous (PV) inflow and its momentum at
mitral valve opening (MVO), which may vary indepandentof intrinsic LV dias-
tolic properties and initial diastolic LAP; for example, PV momentum at MVO
is near zero in atrfal fibrillation. We studied this effect in two ways: (1) Math-
ematiceily, by mmbining an elaatance model for pressure with the unsteady
Bernoulli equation into a system of differential equationa to derive an analyt-
ical solution for the E wave related to PV, LA, and LV.diastolic mmplianca
and relaxation time; IA pressure and PV velocity at MVO; as well as PV and
mitral inertance and area. (2) In 9 open-cheat dogs under right-heart bypass
to measure the E wave in the beat before and after computer controlled PV
occlusion at MVO. Results: The mathematical simulation showad that with
all other factors being equal, including initial LAP, as the initial PV velocity
decreased from 40 crris to zero, the E wave peak velocity and deceleration
time decreased to 70% of their initial values. Under comparable conditions
in vivo, the same magnitude of change was obsewed (peak E = 70.4 + 15.8
VS. 50.8 + 12.1 CNdS, II < 0.05).
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Conclusions: The initial PV”flow momentum is an important additional
determinant of the E-wave because it suppofls atrial pressure. This momen-
tum may vary independent of intrinsic LV diastolic properties and initial LAP.
Therefore the initial velocity of PWflow should be considered in physiologic
assessments of diastolic function based on the E wave.
I 1003-1121 DecreaseOfMitraiRegurgitationWithHeart
FailureTreetmentis Dueto a Reductioninthe
RegurgitantOrifice
L.B. Rosario, R.T.Lee, S.D. Solomon, L.W. Stevenson, S.C. Reimold.
Brigham and Women’s Hospital, Boston, MA, USA
Although treatment of congestive heart failure is associated with a dacraaaa
in the severity of mitral regurgitation, the mechanisms for this reduction
are incompletely understood. To explore mechanisms for this decrease, we
performed echocardiography before and after therapy to decrease filling
pressures in 12 patients with heart failure. In addition to hemcdynamic vari-
ables, echocardiographic variables were measured blindly. Mitral regurgitant
flow was determined from color m-mode proximal isovelocity surface areaa
and the effective regurgitant orifice area was calculated as: Regurgitant flow
integraVragurgitant velocity integrai. Results: Tailored therapy resulted in a
decrease in systolic blood pressure (104+ 10 mmHg to 92 + 11 mmHg, p =
0.005) and pulmonary wedge pressure (30 + 7 mmHg to 21 + 5 mmHg, p <
0.001). Cardiac index increased from 1.90 + 0.47 to 2.36 + 0.44 Umirdrr?,
(P= 0.03). Mitralregurgitantflowdecreased from 44.4 + 32.6 ml to 11.6+
9.6 ml (p = 0.003). Although the effective regurgitant orifice area decreased
with therapy (0.36 +0.33 cmz to 0.11 * 0.01 cm2, p =0.01), this wee not due
to any change inthe peak Doppler-derivedventriculo-atrialsystolicpressure
gradient(64.4 + 17.8 to 63.1 + 14.4 mmHg,p = NS). Conclusion: Heart fail-
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uretherapyis associatedwitha reductionin mitralregurgitantvolume.This
reductionin regurgitantvolumeis notdueto a changeintheventricule-atrial
pressuregradientbut ia a resultof a decreasein the effectiveregurgitant
orificearea.
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D.Pagano,J.N.Townend,R.S.Bonser,P.G.Camici.QueenE/izabat/r
Hoapita/BhrrrirrghamandMRCarrdRPMSHammeramithHospitalLondon,
UK
BothIow-doaedobutamineeohocardiography(LDDE)and‘8Fluoro4eoxygiucose
positronemissiontomography(PET-FDG)are used for the assessment
of myocerdi.slviebilityin patientswith coronaryarterydisease(CAD)and
chronicleftventricular(LV)dysfunction.In this studywe aimedto compare
theirpredictivevalueonlyin patientswithsevereleftventriculardysfunction
and heartfailure.30 patients[meanradionuclide(MUGA)ejectionfraction
23 + 7%; NYHAclass?111]underwentLDDE(5 and 10 ~cg/f@min)and
quantitativePET-FDG(hyperinsulinemiceuglyceemicclamp)beforecoro-
naryatterybypass(CAB).DysfunctionalLVsegments(DS)wereconsidered
viableif wallmotionscore(WMS)eitherimpmvedor showeda biphaaicre-
sponseat LDDEandlorthe myocardialrateof glucoseutilisationwas20.25.
,umol/minfgat PET-FDG.Regional(echo)and global(MUGA)LVfunction
wasassessedat baselineand6 monthsafterCAB.Themeanpoatoperative
EF wasincreasedto 33 A 9% (p <0.0001 vs basal).Outof 330 DSseg-
mentsrevaaoularised190(57%)showedimprovedfunctionfollowingCAB
(trulyviable).Ofthese166(99%)werePET-FDGviableand116(61Y0)were
LDDEviable(p < 0.0001).Althoughthe positivepredictivevalue(PPV)of
PET-FDGandLDDEwaseimilar(67and69Y0,respectively,p=ns) thenega-
tivepredictivevalueofPET-FDGwashigherthenLODE(96veraua54Y0,p <
0.0001).Asa result70/162DSnonviableat LDDEImprovedfunctionfollow-
ingsurgery(37V0of all DSimproving).A linearrelationbetweenthenumber
of DSimpmvingWMSandthe absolutechangesin EFin eachpatient(r=
0.76,.p-=0.0001)and betweenthe numberof PET-FDGviableDsandthe
absolutechangesin EF in eachpatient = 0.65,p < 0.0001)weafound.
Conclusions:InthesepatientswithchronicsevereLVdysfunctionandheart
failure,reooveyafterrevascularisationcorrelateslinearlywiththenumbarof
viablesegmentaidentifiablepreoperatively.PET-FDGoffersa moreaccurate
predictionof outcomethanLDDE.
m1 Q E cAR G
V D M
C hN V
A.K.Costa,M.Areenault,E.Avelar,M.Vannan,G.Marx,N.Pandian.
Tufts-NewEnglMedCtr Boston,MA,USA
Althoughventricularshapeinfluencesfunctionand prognosis,the assess-
mentof RV ahapehaa been primarilyqualitativebacsuseof its complex
geometry.Toprovidean objactivequantitativeapproachwe havedevel-
opeda dedicatedoomputeflzedquantitativemethodto analyzeregionaland
g/oba/RVshspefrom2-Dechostudies,andappliedit to characterizingthe
RV ahapeof normalhumans.Fromdigitizedimagesof the RV in apical
4-chamberview(4CV)and parasternalshort-axisview(SAX)of 21 normal
subjects,the endocardialborderswereextractedat end-diastole(ED)and
end-aystole(ES).Quantitativeregionalcurvature(C)analyaiswasemployed
(at 100pointaof cavityoutline)to evaluateregionalehapa(higherC = more
curved,lowerC = flatter);Fourieranalysiswas usedto deriveindicesof
globalshape(FourierPowerIndexor Pl; lowerPl= moreaphericel).Reau/ta:
(mean+ SE,* p < 0.05): In 4CY RVfree wall was mildlycurvedat ED
but relativelyflattenedat ES(D:1O+ 1 vs.S:6+ l*). Septumhadnegative
curvatureat ED(-1.5 + 1.3)anddidnotchangeduflngsystole(-1.9 +5). C
valuesforhighlycurvedRVapexwereD:31.5+ 1.6,S:34.3+ 1.9.GlobalRV
shapewasmaintainedfromEDto ES(24.0+ 1.6and28.7+ 2.2).In SAX,
RVfree wall demonstratedamoothcwvatureat ED (12.1+ 0.6), septum
negativeC (-3.2 + 0.5)andfreewall-septaljunctionshadhighestC values
asexpected(64+7 and67 + 7);Theahapewasmaintainedduringsystole
with no significantchangein any part. Weconcludethat this quantitative
shapeanalyeisIse&ailyappliedto theRVandprovidesnormalbaselinedata
on regionaland global RV shape.This couldaid in futurestudieaon the
pathophysiologicimplicationsof shapechangesin RVdisorders.
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B.Kuch,H.W.Hense,M.Muscholl,U.Brockel,A. Doering,G’.A.J.Riegger,
H.Schunkert.Epidernio/ogykrstitute,UnivecsifyofkfiirratefiGermany,C/inic
of InternalMedicine//, UnivecsifyofRegensburg,GarmanKGSF
Nauherbarg,Germany
Hormonereplacementherapy(HFtT)ia prospectivelyassociatedwith a
Iowercerdiovaaoularriskinpostmenopausalwomenbutthefaotorainvolved
remainpartlyunknown.We investigatedthe assmiationof HRTand left
ventricular(LV)mesadeterminedby M-modeechocardiography,a strong
pradiotorofcoronaryrisk,in574post-menopausalwomenfromtheMONICA
AugsburgEcho-Study.Of theaewomen(meanage 59.2 + 0.3 years),48
werecurrentlyrakingunopposedestrogens(ERT,meanage56.9+0.8) and
73 usedanestrogen-pmgestincombination(EPRT,mean56.8+ 0.6).After
controlof agedifferences,EPRT(butnotERT)womenshowadsubstantially
lowerheight-indexedLVmassesthanwomenwithoutreplacementherapy
(90.1vs. 101.6@m,p = 0.0018).Of note,additionalcontrolfor differences
in bodymessand bloodpreasurereducedthis differenceto 3.7 g/m (p =
0.26).Likewise,the prevalenceof LVhypertrophywaslowin EPRTwomen
comparedwithuntreatedwomen(26vs43%,age-adjustedoddsretioO.54,p
=0.03),however,differencesinbodymassandbloodpreesureaccountedfor
moatof it (fullyadjustedoddsratio=0.89,p= 0.7).ConcentricLVhypartmphy
wasparticularlyrarein EPRTwomen(7%)andthe relativeoddscompared
to untreatedwomenremainedlowevenaftercontrolof majorconfounders:
OR= 0.5,95%confidenceinterval0.2 to 1.2.Noeffectswereseenfor ERT
women.
In aummary,postmenopausalwomenon EPRTexhibitmarkedlylower
LV massand hypertrophycomparedto womentakingestrogenaaloneor
usingnohormonalreplacement.Mostofthisdifferenceisexplainedbymore
favorablelevelsof body massand blood pressurein EPRTwomen.We
suppae thattheabsenceofaneffectinwomenusingunopposedestr~gans
mayarisefroma currentlycommonshiftin the indicationof this replacement
regimentoalmostexclusivelywomenaftersurgioalmenopausewhichislikely
to havemnfoundedtheresultsin thiscroas-sactionalstudies.Inconclusion,
our findingsmayhelpto understandpreviousreportson steeprisesin LV
massaftermenopauseandtofurtherexplaintheassociationbetweenEPRT
andlowcoronaryrisk.
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Nakatani,K.Kohyama,M.Uematsu,Y.Yasumura,M.Yamagishi,
K.Miyateke.Natiorr8/Cardiovae6u/arCente~Suita,Japan
AlthoughIeftatrial%ompliance”plays animportantroleinmaintainingcardisc
outputand preventingpulmonarycongestion,therehavebeenno clinically
applicablequantificationmethodsto date.Flowpropagationvelocity(FPV)
easesaedwith colorM-modeDopplerhas been propoaedas an indexof
chambercompliance.We appliedthis conceptto the left atrium and pul-
monaryvenousflow,andaimedto determinewhetheror notcolorM-mode
derivedsystolicpulmonaryvenousFPVcouldreflectleftatrial“compliance”.
MethodsWe studied51 patientswith sinusrhythmusingtransthorecic
echocardiography.35 werenormal(N,49 + 19yeare)and 16 hadvarious
cardiacdiseaseswhichcouldstiffenthe left atrium(myocardialinfarction,
severehypertension,dilatedcardiomyopathyand aorticstenosis)(D,55 +
18yeam,p=na).TheslopeofcolorM-moderecordingsofsystolicpulmonary
venouaflow (CMS)end peaksystolicpulmonaryvenousflowVekXity(SV)
were measuredin the apical4 chamberview.CMS/Svwas obtainedas
an indexof load-correctedFPV.Leftatrialsystolicdiameterandventricular
systolicanddiastolicdiametersweremeasuredandleftventricularfractional
shorteningweeobtained.
Resu/ts:Age-relatedchangein FPVwassignificantin N (r= -0.70, p <
0.0001),but was not so remarkablein D (r = –0.53, p < 0.05). FPVwas
significantlylowerin D than age-matchedN (0.23+ 0.05 vs 0.29 A 0.05,
p < 0.01).Multivariatelogisticregressionanalyaierevealedthat FPVwas
thebestdiscriminatorbetweenNand D (p = 0.02)amongageandall other
echocardiogrephicparameters.
Conclusions:1)PulmonaryvenousFPVlinearlydecreasedwith
normalsubjects,suggestingage-relateddeteriorationof left atnal compli-
ance.2) Systolicpulmona~venousFPV may be a simplequantification
methodto assessleftatrialcomplianceindependentof leftatrialandventric-
ulareize.
